ArticleCell death & disease2022

Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis.

Yu-Chan Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.